ReGelTec, Inc

medical devices

About

ReGelTec, Inc. is a clinical-stage biomedical and medical device company dedicated to developing innovative treatments for chronic low back pain caused by degenerative disc disease. Their flagship product, the HYDRAFIL® System, is a proprietary injectable hydrogel implant designed for a minimally invasive outpatient procedure. This hydrogel is injected into the nucleus of a degenerated intervertebral disc, where it fills cracks, restores hydration, and mimics the natural properties of a healthy disc to provide pain relief while preserving spinal motion. The HYDRAFIL System has received CE Mark approval for use in Europe and has been granted Breakthrough Device Designation by the FDA, indicating its potential to meet an important medical need. ReGelTec collaborates with healthcare providers specializing in spine care and pain management to offer this treatment to patients. The company is supported by a team of experienced MedTech executives and scientists, focusing on clinical development, regulatory approvals, and commercialization of their innovative implant technology.

Technologies

Outlook Google Tag Manager Mobile Friendly WordPress.org Render Android Remote Circle Domo Sisense

Keywords

medical equipment manufacturing services medical devices biotechnology regenerative medicine regulatory compliance medical technology healthcare hospital & health care health care health wellness & fitness

Location

323 West Camden Street, Baltimore, Maryland, United States, 21201

Related Companies

Companies in the same industry